Search

Search Constraints

You searched for: Author/Creator Thom, George

Search Results

1. A peptide derived from melanotransferrin delivers a protein-based interleukin 1 receptor antagonist across the BBB and ameliorates neuropathic pain in a preclinical model. Issue 10 (October 2019)

2. Antibodies binding the head domain of P2X4 inhibit channel function and reverse neuropathic pain. Issue 9 (September 2019)

3. Brain penetration, target engagement, and disposition of the blood‐brain barrier‐crossing bispecific antibody antagonist of metabotropic glutamate receptor type 1. Issue 5 (2nd February 2016)

4. Brief formula low‐energy‐diet for relapse management during weight loss maintenance in the Diabetes Remission Clinical Trial (DiRECT). Issue 3 (6th January 2021)

6. Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial. Issue 5 (May 2019)

8. Intracellular sorting and transcytosis of the rat transferrin receptor antibody OX26 across the blood–brain barrier in vitro is dependent on its binding affinity. Issue 6 (16th August 2018)

9. Isolation of blood-brain barrier-crossing antibodies from a phage display library by competitive elution and their ability to penetrate the central nervous system. Issue 2 (17th February 2018)

10. Participant experiences in the Diabetes REmission Clinical Trial (DiRECT). Issue 1 (18th September 2021)